PACIFIC VIEW ASSET MANAGEMENT, LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.

Quarter-by-quarter ownership
PACIFIC VIEW ASSET MANAGEMENT, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$4,623,000
-5.0%
222,117
+2.0%
5.02%
-0.8%
Q1 2019$4,866,000
+5.1%
217,730
+12.6%
5.06%
-7.0%
Q4 2018$4,628,000
-10.7%
193,427
+1.9%
5.44%
+31.9%
Q3 2018$5,181,000
-1.0%
189,857
-2.5%
4.12%
-0.5%
Q2 2018$5,233,000
+50.9%
194,628
+78.6%
4.14%
+58.5%
Q1 2018$3,469,000108,9842.61%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders